Highlights Demant A/S Berne S.E.

Equities

Delayed Berne S.E. Other stock markets 12:00:03 2023-11-15 EST			5-day change	1st Jan Change
34.92 ^CHF	-.--%		-19.92%	-6.81%

06-26	Demant Flags Delay in Completion of Communications Business' Strategic Review	MT
05-29	UK’s Competition Regulator Closes Cochlear-Demant Deal	MT

Demant Flags Delay in Completion of Communications Business' Strategic Review	06-26	MT
UK’s Competition Regulator Closes Cochlear-Demant Deal	05-29	MT
Denmark's Demant Completes Sale of Cochlear Implants Business	05-21	MT
Cochlear Limited acquired Oticon Medical A/s from Demant A/S.	05-20	CI
DEMANT : Q1 sales miss; organic growth guidance unchanged	05-06
Hearing Healthcare Company Demant Affirms FY24 Outlook	05-06	MT
Demant A/S Provides Earnings Guidance for the Year 2024	05-06	CI
Competition Regulator Clears Cochlear’s Acquisition of Oticon Medical’s Cochlear Implant Business	04-03	MT
Demant Seeks Acquisitions	03-12	CI
DEMANT : In-line Q4; markets cheer the promising takeaways for 2024	02-06
Global markets live: BP, Palantir, Infineon, Toyota, UBS...	02-06
Tranche Update on Demant A/S's Equity Buyback Plan announced on March 5, 2021.	02-06	CI
Demant A/S Reports Earnings Results for the Full Year Ended December 31, 2023	02-06	CI
Demant Forecasts Up to 8% Organic Revenue Growth in FY24	02-06	MT
Demant A/S Provides Earnings Guidance for the Year 2024	02-05	CI
Demant to Recommence Share Buybacks	11-21	MT
Demant Q3 revenue meets forecast, narrows outlook	11-07	RE
Demant A/S Provides Earnings Guidance for the Year 2023	11-07	CI
European Commission OKs Cochlear's Aquisition of Oticon Medical Unit	23-10-10	MT
Tranche Update on Demant A/S's Equity Buyback Plan announced on March 5, 2021.	23-08-15	CI

No results for this search

DEMANT : Q1 sales miss; organic growth guidance unchanged

May 06, 2024 at 11:18 am